贫血对慢性肢体威胁性缺血血运重建患者一年无截肢生存的影响
这项回顾性队列研究分析了283例因慢性肢体威胁性缺血(CLTI)接受血运重建的患者,其中52.3%存在贫血。结果显示,贫血患者1年无截肢生存(AFS)显著低于非贫血患者(64.2% vs. 78.5%,P=0.009),且中重度贫血和围手术期红细胞输注均与主要截肢/死亡风险独立相关。
要点
- 贫血患者1年AFS显著降低(64.2% vs. 78.5%,P=0.009)。
- 中重度贫血独立增加主要截肢/死亡风险(aHR 1.90,95%CI 1.06-3.38)。
- 围手术期红细胞输注与主要截肢/死亡风险增加独立相关(aHR 3.15,95%CI 1.91-5.20)。
核心结论
- 中重度围手术期贫血及后续红细胞输注均与CLTI血运重建患者1年无截肢生存降低独立相关。
研究设计与样本
- 回顾性队列研究,纳入2018年2月至2019年2月诊断为CLTI并接受血运重建的患者283例。
主要发现
- 148例(52.3%)患者存在贫血,53例(18.7%)接受了红细胞输注。
- 贫血患者1年AFS为64.2%,非贫血患者为78.5%(P=0.009)。
- 贫血严重程度与1年AFS显著相关(P=0.008)。
- 接受红细胞输注的患者1年AFS为45.3%,未输注者为77.0%(P<0.001)。
- 多变量分析显示,中重度贫血独立增加主要截肢/死亡风险(aHR 1.90,95%CI 1.06-3.38,P=0.030)。
临床怎么用
- 对CLTI血运重建患者应评估围手术期贫血及其严重程度,中重度贫血提示1年AFS较差。
- 围手术期红细胞输注与不良结局独立相关,需审慎评估输血指征并探索替代管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anemia is potentially associated with increased morbidity and mortality following vascular surgery procedures. This study investigated whether peri-procedural anemia is associated with reduced 1-year amputation-free survival (AFS) in patients undergoing revascularization for chronic limb-threatening ischemia (CLTI). METHODOLOGY: A retrospective analysis of patients diagnosed with CLTI between February 2018-February 2019, who subsequently underwent revascularization, was conducted. Hemoglobin concentration measured at index assessment was recorded and stratified by WHO criteria. Subsequent peri-procedural red blood cell transfusions (RBC) were also recorded. The primary outcome was 1-year AFS. Kaplan Meier survival analysis and Cox's proportional hazard modelling were conducted to assess the effect of anemia and peri-procedure transfusion on outcomes. RESULTS: 283 patients were analyzed, of which 148 (52.3%) were anemic. 53 patients (18.7%) underwent RBC transfusion. Patients with anemia had a significantly lower 1-year AFS (64.2% vs. 78.5%, P = 0.009). A significant difference in 1-year AFS was also observed based upon anemia severity (P = 0.008) and for patients who received RBC transfusion (45.3% vs 77.0%, P < 0.001). On multivariable analysis, moderately severe anemia was independently associated with increased risk of major amputation/death (aHR 1.90, 95% CI 1.06-3.38, P = 0.030). After adjusting for severity of baseline anemia, peri-procedural RBC transfusion was associated with a significant increase in the combined risk of major amputation/death (aHR 3.15, 95% CI 1.91-5.20, P < 0.001). CONCLUSION: Moderately severe peri-procedural anemia and subsequent RBC transfusion are independently associated with reduced 1-year AFS in patients undergoing revascularization for CLTI. Future work should focus on investigating alternative measures to managing anemia in this cohort.
引用
- Theuma F, Nickinson ATO, Cullen S, et al. The Impact of Anemia on One-Year Amputation-Free Survival in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia: A Retrospective Cohort Study. Ann Vasc Surg. 2021. PMID: 34644651. doi:10.1016/j.avsg.2021.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。